News
- Author:
- Andrew D. Bowser
Publish date: October 26, 2020
Missed OSA diagnoses could have especially negative implications for patients who don’t continue on positive airway pressure (PAP) therapy during t...
News
- Author:
- Andrew D. Bowser
Publish date: October 23, 2020
The clinical benefit of the switching to the sGC inhibitor was consistent across patient subgroups in the phase 4 REPLACE study.
News
- Author:
- Andrew D. Bowser
Publish date: October 22, 2020
Statin use was associated with lower mortality, compared with no use, with hydrophilic and synthetic statins besting lipophilic and fungal-derived ...
News
- Author:
- Andrew D. Bowser
Publish date: October 21, 2020
At the peak of the pandemic in New York City, goals of care discussions became easier, though coping with death remains an issue.
News
- Author:
- Andrew D. Bowser
Publish date: October 19, 2020
Retrospective analysis finds many lung cancer patients would not have counted as eligible for low-dose CT under guidelines that are being reconside...
News
- Author:
- Andrew D. Bowser
Publish date: October 18, 2020
Top health official is “cautiously optimistic” for vaccine distribution before end of year, pending favorable safety and efficacy data.
News
- Author:
- Andrew D. Bowser
Publish date: September 16, 2020
No increase was seen in hospitalization and death rates, providing additional support for keeping patients on these immunosuppressive treatments du...
News
- Author:
- Andrew D. Bowser
Publish date: July 13, 2020
The median progression-free survival was significantly longer for patients with circulating tumor DNA clearance.
News
- Author:
- Andrew D. Bowser
Publish date: July 1, 2020
Average fluid cognition scores were significantly lower versus youths with type 1 diabetes, a difference investigators said was due to further defi...
News
- Author:
- Andrew D. Bowser
Publish date: June 30, 2020
The combination produced a response rate of 46%.
News
- Author:
- Andrew D. Bowser
Publish date: June 29, 2020
The risk of death was reduced regardless of age, sex, race, or duration of lipid-lowering drug use.
News
- Author:
- Andrew D. Bowser
Publish date: June 25, 2020
Combining a personalized vaccine, RO7198457, with atezolizumab produced many immune responses but few clinical re...
News
- Author:
- Andrew D. Bowser
Publish date: June 23, 2020
The finding reflects increases in diabetes-related nontraumatic lower extremity amputation occurring in younger U.S. population, but at a less seve...
News
- Author:
- Andrew D. Bowser
Publish date: June 23, 2020
Fasting plasma glucose normalized in over 60%, suggesting normal-weight individuals should not be excluded from c...
News
- Author:
- Andrew D. Bowser
Publish date: June 17, 2020
It’s “essential” to avoid drugs associated with hypoglycemia to minimize CV event risk in patients with type 2 diabetes, investigator says.
